TY  - JOUR

T1  - Progressive and Sustained Disease Control in Patients with Atopic Dermatitis (AD) Aged 12–17 Years Treated with Tralokinumab for 52 Weeks

JO  - SKIN The Journal of Cutaneous Medicine

UR  - http://dx.doi.org/10.25251/skin.8.supp.377

PY  - 2024/03/18

AU  - Wollenberg A

AU  - Cork M

AU  - Hong C-H

AU  - Kurbasic A

AU  - Vacko E

AU  - Paller A

ED  - 

DO  - DOI: 10.25251/skin.8.supp.377

PB  - National Society for Cutaneous Medicine

VL  - 8

IS  - 2

SP  - s377

EP  - s377

Y2  - 2024/12/22

ER  -